المؤلفون: Panjavania, Rashmi R.¹, Tripathia, Sakshi V.¹, Sharmaa, Chandramauly R.¹ drcrsharma10@gmail.com

المصدر: Indian Drugs. Nov2024, Vol. 61 Issue 11, p67-77. 11p.

مصطلحات موضوعية: *BEER-Lambert law, *ALBENDAZOLE, *QUALITY control, *DETECTION limit, *QUALITY assurance

المؤلفون: Cole, Susan¹ (AUTHOR) susan.cole@mhra.gov.uk, Malamatari, Maria¹ (AUTHOR), Butler, Andrew¹ (AUTHOR), Arshad, Mahnoor² (AUTHOR), Kerwash, Essam¹ (AUTHOR)

المصدر: CPT: Pharmacometrics & Systems Pharmacology. Nov2024, Vol. 13 Issue 11, p1990-2001. 12p.

مصطلحات موضوعية: *ALBENDAZOLE, *INFANTS, *PHARMACOKINETICS, *ADULTS, *BREASTFEEDING, *LACTATION, *BREAST milk

المؤلفون: Sadia, H.¹, Imran, M.² imran.asghar@uaf.edu.pk, Shahid, A.³, Shahbaz, Z.⁴, Murtaza, G.⁵, Adil, M.⁶, Nasir, I.¹, Khalid, M. H.⁶, Haider, S.⁶, Saeed, Z.²

المصدر: Nigerian Journal of Parasitology. Sep2024, Vol. 45 Issue 2, p479-482. 4p.

مصطلحات موضوعية: *PLANT extracts, *ALBENDAZOLE, *ADULTS, *MORTALITY, *NEEM, *EGGS

المؤلفون: Kenya Medical Research Institute, Jomo Kenyatta University of Agriculture and Technology, International Centre of Insect Physiology and Ecology (ICIPE)

المصدر: Evaluating the Impact of an Improved Household Flooring Intervention on Enteric and Parasitic Infections in Rural Settings in the Counties of Bungoma and Kwale, Kenya

المصدر: An Open Label, Balanced, Randomized, Two-Treatment, Four-Period, Two-Sequence, Single Oral Dose, Full Replicate Crossover, Bioequivalence Study of Albendazole Tablets IP 400 mg of Biddle Sawyer Limited (GSK Group Company) With Albendazole Tablets 400 mg of Glaxo SmithKline Consumer Healthcare, South Africa (PTY) Ltd in Healthy, Adult Participants Under Fed Condition

Other URLs: https://www.gsk.com/en-gb/innovation/trials/data-transparency/

المؤلفون: Vector Borne & Neglected Tropical Disease Control Division, Ministry of Health, Uganda, Makerere University

المساهمون: Jennifer Keiser, Prof. Dr.

المصدر: The Feasibility and Acceptability of the Co-administration of Ivermectin and Albendazole vs Albendazole Alone, in the Frame of Mass Drug Administration to School-aged Children in Uganda: A Small-scale Implementation Pilot Study

المؤلفون: Okumura, Nobumasa¹ (AUTHOR) nokumura@hosp.ncgm.go.jp, Yamamoto, Kei¹ (AUTHOR) kyamamoto@hosp.ncgm.go.jp, Ohmagari, Norio¹ (AUTHOR) nohmagari@hosp.ncgm.go.jp

المصدر: Journal of Infection & Chemotherapy (Elsevier Inc.). Aug2024, Vol. 30 Issue 8, p796-799. 4p.

مصطلحات موضوعية: *TOXOCARIASIS, *ALBENDAZOLE, *FOOD poisoning, *JAPANESE people, *DISEASE relapse, *LUNG diseases

مصطلحات جغرافية: EAST Asia, CHINA

المؤلفون: Pillay-Fuentes Lorente, Veshni^1,2 (AUTHOR), Nwogu-Attah, Jacinta N.^2,3 (AUTHOR) nwogu.jacinta@lcu.edu.ng, Steffens, Britta⁴ (AUTHOR), Bräm, Dominic⁴ (AUTHOR), Sprecher, Viviane^5,6 (AUTHOR), Hofmann, Daniela⁵ (AUTHOR), Buettcher, Michael^4,6,7 (AUTHOR), Pillai, Goonaseelan^2,8,9 (AUTHOR), Mouksassi, Samer¹⁰ (AUTHOR), Coulibaly, Jean^11,12 (AUTHOR), Pfister, Marc⁴ (AUTHOR), Keiser, Jennifer^5,6 (AUTHOR)

المصدر: Drugs in R&D. Jun2024, Vol. 24 Issue 2, p331-340. 10p.

مصطلحات موضوعية: *IVERMECTIN, *ALBENDAZOLE, *PUBLIC health, *WHIPWORMS, *PHARMACOKINETICS, *METABOLITES

المؤلفون: Rani, Vijay¹, Gehlawat, Virender K.¹, Arya, Vandana¹ vandanaarya001@gmail.com

المصدر: Journal of Family Medicine & Primary Care. Jun2024, Vol. 13 Issue 6, p2300-2304. 5p.

مصطلحات موضوعية: *NEUROCYSTICERCOSIS, *ALBENDAZOLE, *RANDOMIZED controlled trials, *PRAZIQUANTEL, *CALCIFICATION

المؤلفون: Public Health Laboratory Ivo de Carneri

المساهمون: Jennifer Keiser, Prof. Dr.

المصدر: Efficacy and Safety of Moxidectin and Albendazole Compared to Ivermectin and Albendazole Co-administration in Adolescents Infected With Trichuris Trichiura: a Randomized Controlled Trial
Welsche S, Mrimi EC, Hattendorf J, Hurlimann E, Ali SM, Keiser J. Efficacy and safety of moxidectin and albendazole compared with ivermectin and albendazole coadministration in adolescents infected with Trichuris trichiura in Tanzania: an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Lancet Infect Dis. 2023 Mar;23(3):331-340. doi: 10.1016/S1473-3099(22)00589-8. Epub 2022 Oct 28.
Welsche S, Mrimi EC, Keller L, Hurlimann E, Hofmann D, Hattendorf J, Ali SM, Keiser J. Efficacy and safety of moxidectin and albendazole compared to ivermectin and albendazole co-administration in adolescents infected with Trichuris trichiura: a randomized controlled trial protocol. Gates Open Res. 2021 Sep 27;5:106. doi: 10.12688/gatesopenres.13299.2. eCollection 2021.

المؤلفون: Oxfendazole Development Group

المصدر: A Double-blind Multicenter, Randomized Controlled Trial of Single and Multiple Dose Regimens of Oxfendazole for Mild (One or Two Lesions) Parenchymal Brain Cysticercosis, With an Open Comparison Group

المؤلفون: UNITAID

المصدر: A Phase III Cluster-randomized, Open-label, Clinical Trial to Study the Safety and Efficacy of Ivermectin Mass Drug Administration to Reduce Malaria Transmission in Two African Settings

المصدر: A Randomized, Double Blind, Parallel Group Clinical Trial to Evaluate the Safety of Moxidectin Compared With Ivermectin in Individuals Living in Onchocerciasis Endemic Areas and in Individuals Living in Onchocerciasis Endemic Areas With High Levels of Lymphatic Filariasis Co-endemicity Receiving Concomitant Treatment With Albendazole

المساهمون: Omnya atef Mahmoud Abdelbaky, Doctor

المصدر: Daily Versus Alternate Day Regimen of Iron Supplementation in Children with Iron Deficiency Anemia: a Hospital Based Study

Other URLs: https://osf.io/

المؤلفون: Institut de Recherche pour le Developpement, France

المصدر: Randomized, Double-blind Trial Evaluating the Safety and Efficacy of a 21-day Course of Albendazole 400mg/Day in Subjects With High Loa Loa Microfilaremia

المساهمون: Thareerat Ananchaisarp, Principal Investigator

المصدر: Comparison of Outcome Between Specific Anthelminthic Treatment According to Test Results and Empirical Anthelminthic Treatment in Eosinophilic Patient
Chanswangphuwana C, Uaprasert N, Moonla C, Rojnuckarin P. Causes and outcomes of hypereosinophilia in a tropical country. Asian Pac J Allergy Immunol. 2021 Apr 18. doi: 10.12932/AP-221220-1021. Online ahead of print.
Ananchaisarp T, Chamroonkiadtikun P, Julamanee J, Perdvong K, Chimpalee T, Rattanavirakul N, Leelarujijaroen N, Hathaipitak T, Tantinam T. Prevalence and management of eosinophilia based on periodic health examinations in primary care clinics. Asian Biomed (Res Rev News). 2023 Jun 16;16(5):273-282. doi: 10.2478/abm-2022-0030. eCollection 2022 Oct.
Shomali W, Gotlib J. World Health Organization-defined eosinophilic disorders: 2022 update on diagnosis, risk stratification, and management. Am J Hematol. 2022 Jan 1;97(1):129-148. doi: 10.1002/ajh.26352. Epub 2021 Oct 8.
Butt NM, Lambert J, Ali S, Beer PA, Cross NC, Duncombe A, Ewing J, Harrison CN, Knapper S, McLornan D, Mead AJ, Radia D, Bain BJ; British Committee for Standards in Haematology. Guideline for the investigation and management of eosinophilia. Br J Haematol. 2017 Feb;176(4):553-572. doi: 10.1111/bjh.14488. Epub 2017 Jan 23. No abstract available.
Magnaval JF, Laurent G, Gaudre N, Fillaux J, Berry A. A diagnostic protocol designed for determining allergic causes in patients with blood eosinophilia. Mil Med Res. 2017 May 23;4:15. doi: 10.1186/s40779-017-0124-7. eCollection 2017.
Vaisben E, Brand R, Kadakh A, Nassar F. The role of empirical albendazole treatment in idiopathic hypereosinophilia - a case series. Can J Infect Dis Med Microbiol. 2015 Nov-Dec;26(6):323-4. doi: 10.1155/2015/531675.
Insiripong S, Siriyakorn N. Treatment of eosinophilia with albendazole. Southeast Asian J Trop Med Public Health. 2008 May;39(3):517-20.
Chen B, Fu Y, Wang Z, Rong Q, Zhang Q, Xie J, Kong X, Jiang M. Eosinophilia attention, diagnosis, treatment, and awareness in physicians: a cross-sectional survey. Ther Adv Chronic Dis. 2023 Jan 24;14:20406223221146938. doi: 10.1177/20406223221146938. eCollection 2023.
Kim DW, Shin MG, Yun HK, Kim SH, Shin JH, Suh SP, Ryang DW. [Incidence and causes of hypereosinophilia (corrected) in the patients of a university hospital]. Korean J Lab Med. 2009 Jun;29(3):185-93. doi: 10.3343/kjlm.2009.29.3.185. Erratum In: Korean J Lab Med. 2010 Apr;30(2):202. Korean.
Wardlaw AJ, Wharin S, Aung H, Shaffu S, Siddiqui S. The causes of a peripheral blood eosinophilia in a secondary care setting. Clin Exp Allergy. 2021 Jul;51(7):902-914. doi: 10.1111/cea.13889. Epub 2021 Jun 3.
Tefferi A, Patnaik MM, Pardanani A. Eosinophilia: secondary, clonal and idiopathic. Br J Haematol. 2006 Jun;133(5):468-92. doi: 10.1111/j.1365-2141.2006.06038.x.
Guo C, Bochner BS. Workup for eosinophilia. Allergy Asthma Proc. 2019 Nov 1;40(6):429-432. doi: 10.2500/aap.2019.40.4264.
Kuang FL. Approach to Patients with Eosinophilia. Med Clin North Am. 2020 Jan;104(1):1-14. doi: 10.1016/j.mcna.2019.08.005.
Rosenwasser LJ. Approach to patients with eosinophilia. Mo Med. 2011 Sep-Oct;108(5):358-60.
Simon D, Simon HU. Eosinophilic disorders. J Allergy Clin Immunol. 2007 Jun;119(6):1291-300; quiz 1301-2. doi: 10.1016/j.jaci.2007.02.010. Epub 2007 Apr 2. Erratum In: J Allergy Clin Immunol. 2007 Sep;120(3):515.
Carranza-Rodriguez C, Escamilla-Gonzalez M, Fuentes-Corripio I, Perteguer-Prieto MJ, Garate-Ormaechea T, Perez-Arellano JL. Helminthosis and eosinophilia in Spain (1990-2015). Enferm Infecc Microbiol Clin (Engl Ed). 2018 Feb;36(2):120-136. doi: 10.1016/j.eimc.2015.11.019. Epub 2016 Jan 27. English, Spanish.
Khoury P, Bochner BS. Consultation for Elevated Blood Eosinophils: Clinical Presentations, High Value Diagnostic Tests, and Treatment Options. J Allergy Clin Immunol Pract. 2018 Sep-Oct;6(5):1446-1453. doi: 10.1016/j.jaip.2018.04.030.
Khanna V, Tilak K, Mukhopadhyay C, Khanna R. Significance of Diagnosing Parasitic Infestation in Evaluation of Unexplained Eosinophilia. J Clin Diagn Res. 2015 Jul;9(7):DC22-4. doi: 10.7860/JCDR/2015/12222.6259. Epub 2015 Jul 1.

المؤلفون: Rutgers, The State University of New Jersey, Jawaharlal Institute of Postgraduate Medical Education & Research

المصدر: Tuberculosis- Learning the Impact of Nutrition
Cintron C, Narasimhan PB, Locks L, Babu S, Sinha P, Rajkumari N, Kaipilyawar V, Bhargava A, Maloomian K, Chandrasekaran P, Verma S, Joseph N, Johnson WE, Wanke C, Horsburgh CR Jr, Ellner JJ, Sarkar S, Salgame P, Lakshminarayanan S, Hochberg NS. Tuberculosis-Learning the Impact of Nutrition (TB LION): protocol for an interventional study to decrease TB risk in household contacts. BMC Infect Dis. 2021 Oct 12;21(1):1058. doi: 10.1186/s12879-021-06734-z.

المؤلفون: Nieves, E.¹ (AUTHOR), Cimino, R.¹ (AUTHOR), Krolewiecki, A.¹ (AUTHOR), Juarez, M.¹ (AUTHOR), Lanusse, C.^2,3 (AUTHOR), Alvarez, L.^2,3 (AUTHOR), Ceballos, L.^2,3 (AUTHOR) lauceballosf@gmail.com

المصدر: Scientific Reports. 3/15/2024, Vol. 14 Issue 1, p1-13. 13p.

مصطلحات موضوعية: *PATIENT compliance, *ALBENDAZOLE, *DRUG administration, *SALIVA, *EXCRETION, *METABOLITES

المؤلفون: Drugs for Neglected Diseases

المصدر: A Phase-II, Randomised, Double-blind, Parallel-group, Proof-of-concept Trial to Investigate ABBV-4083 Given for 7 or 14 Days or in Combination With Albendazole in Subjects With Onchocerca Volvulus Infection, Comprising: Part 1 to Investigate Safety, Tolerability, Efficacy for Dose-Ranging and Pharmacokinetics; Part 2 to Investigate Efficacy of Selected Doses, Safety, Tolerability and Pharmacokinetics

المؤلفون: Public Health Laboratory Ivo de Carneri

المساهمون: Jennifer Keiser, Prof. Dr.

المصدر: Efficacy and Safety of Moxidectin-albendazole Combination for Trichuris Trichiura Infections in School-aged Children: a Double-blind Randomised Controlled Superiority Trial